30.16 USD
+0.14 (+0.47%)
30.16 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 82% to UPB. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 49.47. This target is 64.03% above the current price.
- UPB was analyzed by 12 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about UPB.
- In the previous month the buy percentage consensus was at a similar level.
- UPB was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-18 | Mizuho | Initiate | Outperform |
| 2025-12-02 | LifeSci Capital | Initiate | Outperform |
| 2025-11-18 | Evercore ISI Group | Initiate | Outperform |
| 2025-10-14 | Truist Securities | Initiate | Buy |
| 2024-11-05 | TD Cowen | Initiate | Buy |
| 2024-11-05 | William Blair | Initiate | Outperform |
| 2024-11-05 | JP Morgan | Initiate | Overweight |
| 2024-11-05 | Piper Sandler | Initiate | Overweight |
UPSTREAM BIO INC / UPB FAQ
What is the price target for UPB stock?
12 analysts have analysed UPB and the average price target is 49.47 USD. This implies a price increase of 64.03% is expected in the next year compared to the current price of 30.16.
What is the consensus rating for UPB stock?
The consensus rating for UPSTREAM BIO INC (UPB) is 81.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed UPSTREAM BIO INC (UPB)?
The number of analysts covering UPSTREAM BIO INC (UPB) is 12.